United States · 
Who invested in Neumora Therapeutics?
Neumora Therapeutics's investors include Polaris Partners, ARCH Venture Partners, SoftBank, SoftBank Vision Fund and Catalio Capital Management, and 1 more on record.
United States · Funded startup
Who invested in Neumora Therapeutics
Funding summaryUpdated 26 Oct 2026
$2.6Mraised across 1 round since 2024, from 1 source
- Latest round
- Grant, $2.6MApr 2024
- Investors
- 6
The rounds
- Apr 2024
Founders and team
From Neumora Therapeutics's own website and the SEC filings it signed: 6 on the team.
- Sarah CarterSenior Vice President, Clinical Operations
- Amy SullivanChief Human Resources Officer
- Jason DuncanChief Legal & Administrative Officer
- Joshua PintoExecutive Officeri
- Paul L. BernsExecutive Chair
- Tamara TompkinsExecutive Officeri
On the board, as filediKari StefanssonMatthew FustMaykin HoRobert NelsenStacie Weninger
Everyone who backed them
SoftBank Vision FundVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Neumora Therapeutics
How much has Neumora Therapeutics raised?
Neumora Therapeutics has raised $2.6M across 1 round since 2024.
When did Neumora Therapeutics last raise?
Neumora Therapeutics's most recent round was a Grant of $2.6M in Apr 2024.
What was Neumora Therapeutics's biggest round?
Its most recent round, $2.6M in Apr 2024, is also its largest on record.
Who backed Neumora Therapeutics first?
Neumora Therapeutics's first round on record, in Apr 2024, was backed by Polaris Partners, ARCH Venture Partners and SoftBank and 3 others.
What stage is Neumora Therapeutics at?
Neumora Therapeutics's latest named round is a Grant, in Apr 2024.
Where is Neumora Therapeutics based?
Neumora Therapeutics is based in the United States.
Companies like Neumora Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.